Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
At Nordic Science Investments Ltd.
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025 Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Precision oncology, built for Latin America. Point-of-care software and a multimodal cancer atlas.
GenialisVenture round $11.4M · 3 yr ago
Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.
GenomateConvertible Note $2M · 18 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
Blank BioSeed $7.2M · 4 mo ago • 11-50 employees
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
Scipher MedicineVenture round $5.8M · 2 yr ago • Founded 2013 • 201-500 employees
Transforming Treatment in Immunology. Living at the crossroads of precision medicine and AI, Scipher Medicine is a precision immunology…
Alterome1 role
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…

Overview

Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.

News

News University of Helsinki 1 year ago
Solid IO enables faster access to personalised cancer therapies Helsinki Innovation Services
The spinout company Solid Immuno-Oncology Oy has developed a technology that significantly reduces the time and cost associated with developing cancer treatments. Additionally, it allows for the personalisation of cancer therapies for patients. The compan
Read more
Report
News University of Helsinki 3 years ago
SOLID-IO helps develop new immunotherapies for cancer patients faster and cheaper Helsinki Innovation Services
The new drug testing innovation is based on tumor-on-a-chip technology, the market for which is growing rapidly. If successful, SOLID-IO could support not only drug development but also the selection of treatments for cancer patients in the future.
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Helsinki Finland
HQ
Contact us
10-50 est. staff
00290 Helsinki
company site